Oncology Imperatives: Decentralized Clinical Trials (DCT)

Decentralizing Oncology Clinical Trials

Listen as Dr. Dave Frakes, vice president and global medical officer for PPD® Biotech, hosts a discussion with PPD’s decentralized clinical trial experts, Simon Coggins, vice president and digital solutions lead for our hematology and oncology therapeutic unit, Mariah Baltezegar, vice president of peri and post-approval study innovation, and Tim Rich, vice president of consulting innovation and strategy for PPD Digital. They discuss the current state of oncology clinical trials and the benefits of decentralization.

Learn more about our proven oncology and hematology experience.